Skip to content

B Group, Inc.

Reporting owner on Forms 3, 4 and 5, CIK 2043476.

B Group, Inc. reported on 1 issuer in 10 filings, the latest a 13F-HR filed 2026-11-16.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Retension Pharmaceuticals, Inc. CIK 200298810% owner12026-10-16

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
Retension Pharmaceuticals, … Common Stock, holding 833,333Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13F-HR 0001420506-26-002733 Quarter ended 2026-09-302026-11-16
Form 3 0001213900-26-110379 Retension Pharmaceuticals, Inc.2026-10-16
13G 0001213900-26-110378 RTSN2026-10-16
13F-HR 0001420506-26-001657 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001420506-26-001023 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001420506-26-000462 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001420506-25-003231 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001420506-25-002005 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001420506-25-001152 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001420506-25-000436 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set